Biogen MA Inc. et al v. Somerset Therapeutics, LLC et al
| Biogen MA Inc., Biogen Inc., Cold Spring Harbor Laboratory and Ionis Pharmaceuticals, Inc. |
| Somerset Therapeutics Private Limited, Somerset Therapeutics, LLC, Somerset Pharma, LLC, Somerset Therapeutics Limited and Odin Pharmaceuticals, LLC |
| 1:2026cv00735 |
| June 22, 2026 |
| U.S. District Court for the District of Delaware |
| Colm F Connolly |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on July 2, 2026. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 16
SO ORDERED, re (16 in 1:26-cv-00580-CFC, 14 in 1:26-cv-00735-CFC, and 10 in 1:26-cv-00736-CFC) STIPULATION Regarding Consolidation and Scheduling Conference filed by Biogen MA Inc., Biogen Inc. The Somerset I, Somerset II, and Cipla Actions are consolidated for all purposes. All filings shall be made in the lead case, C.A. No. 26-580-CFC. The July 9, 2026 Telephonic Scheduling Conference is RESCHEDULED to August 6, 2026 at 2:00 p.m. See Order for further details. Signed by Judge Colm F. Connolly on 7/2/2026. Associated Cases: 1:26-cv-00580-CFC, 1:26-cv-00735-CFC, 1:26-cv-00736-CFC(mws)
|
| Case associated with lead case: Create association to 1:26-cv-00580-CFC. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 26-580-CFC ONLY. (mws) |
| Filing 15 Letter to The Honorable Colm F. Connolly from Karen Jacobs - re (16 in 1:26-cv-00580-CFC, 10 in 1:26-cv-00736-CFC, 14 in 1:26-cv-00735-CFC) STIPULATION and [Proposed] Order Regarding Consolidation and Scheduling Conference . (Jacobs, Karen) |
| Filing 14 STIPULATION and [Proposed] Order Regarding Consolidation and Scheduling Conference - filed by Biogen Inc., Biogen MA Inc.. (Jacobs, Karen) |
| Filing 13 SUMMONS Returned Executed by Cold Spring Harbor Laboratory, Biogen Inc., Biogen MA Inc., Ionis Pharmaceuticals, Inc..Odin Pharmaceuticals, LLC served on 6/24/2026, answer due 7/15/2026. (Tigan, Jeremy) |
| Filing 12 SUMMONS Returned Executed by Biogen MA Inc., Biogen Inc., Cold Spring Harbor Laboratory, Ionis Pharmaceuticals, Inc..Somerset Therapeutics Private Limited served on 6/24/2026, answer due 7/15/2026. (Tigan, Jeremy) |
| Filing 11 SUMMONS Returned Executed by Biogen Inc., Cold Spring Harbor Laboratory, Biogen MA Inc., Ionis Pharmaceuticals, Inc..Somerset Pharma, LLC served on 6/24/2026, answer due 7/15/2026. (Tigan, Jeremy) |
| Filing 10 SUMMONS Returned Executed by Ionis Pharmaceuticals, Inc., Biogen Inc., Biogen MA Inc., Cold Spring Harbor Laboratory.Somerset Therapeutics, LLC served on 6/24/2026, answer due 7/15/2026. (Tigan, Jeremy) |
| Filing 9 JUDGE COLM F. CONNOLLY STANDING ORDERS. Parties shall comply with all applicable standing orders and consult the Court's website for updates. (mws) |
| Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:26-cv-00735-UNA, 1:26-cv-00736-UNA (alb) |
| Filing 8 Summons Issued as to Odin Pharmaceuticals, LLC on 6/23/2026; Somerset Pharma, LLC on 6/23/2026; Somerset Therapeutics Private Limited on 6/23/2026; Somerset Therapeutics, LLC on 6/23/2026. (Attachments: #1 Summons Issued, #2 Summons Issued, #3 Summons Issued)(lah) |
| CORRECTING ENTRY: The Corporate Parent/Other Affiliate information at D.I. #6 has been corrected. (nms) |
| Filing 7 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Cold Spring Harbor Laboratory. (lah) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliates The Vanguard Group, Inc., Fidelity Management & Research Company LLC, T. Rowe Price Investment Management, Inc., and T. Rowe Price Group, Inc. for Ionis Pharmaceuticals, Inc., filed by Ionis Pharmaceuticals, Inc. (lah) Modified on 6/23/2026 (nms). |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Biogen Inc. for Biogen MA Inc. filed by Biogen Inc., Biogen MA Inc.. (lah) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,361,977 B2; 8,980,853 B2; 9,717,750 B2. (lah) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 6/1/2026. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 12/1/2028. (lah) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (lah) |
| Filing 1 COMPLAINT against Odin Pharmaceuticals, LLC, Somerset Pharma, LLC, Somerset Therapeutics Private Limited, Somerset Therapeutics, LLC (Filing fee $405, receipt number ADEDC-4997611) - filed by Cold Spring Harbor Laboratory, Biogen MA Inc., Biogen Inc., Ionis Pharmaceuticals, Inc. (Attachments: #1 Exhibits A-C, #2 Civil Cover Sheet) (lah) |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
